A
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Recent Filings
- SC 13G/A84.0 KBAnacor Pharmaceuticals, Inc.Jul 11, 4:22 PM ET·0001144204-16-112431
- SC 13G/A8.5 KBAnacor Pharmaceuticals, Inc.Jul 11, 12:08 PM ET·0000315066-16-006001
- 420.0 KBAnacor Pharmaceuticals, Inc.Jun 24, 3:36 PM ET·0000950103-16-014342
- 411.9 KBAnacor Pharmaceuticals, Inc.Jun 24, 3:04 PM ET·0000950103-16-014340
- 49.4 KBAnacor Pharmaceuticals, Inc.Jun 24, 2:59 PM ET·0000950103-16-014339
- 419.4 KBAnacor Pharmaceuticals, Inc.Jun 24, 2:58 PM ET·0000950103-16-014338
- 49.8 KBAnacor Pharmaceuticals, Inc.Jun 24, 2:56 PM ET·0000950103-16-014337
- 49.9 KBAnacor Pharmaceuticals, Inc.Jun 24, 2:55 PM ET·0000950103-16-014336
- 429.2 KBAnacor Pharmaceuticals, Inc.Jun 24, 2:49 PM ET·0000950103-16-014335
- 416.4 KBAnacor Pharmaceuticals, Inc.Jun 24, 2:44 PM ET·0000950103-16-014334
Insiders
10- Bell GraemeExecutive VP and CFO
- BERNS PAUL LDirector
- CARE CAPITAL INVESTMENTS II LP10% Owner
- Chanda SanjayVP & Interim Head of Drug Deve
- GSK plc10% Owner
- Heyman Irwin ASenior VP Product Development
- Hong ZhiDirector
- Hove Anders DDirector, 10% Owner
- IPPOLITO VINCENT PEVP & Chief Commercial Officer
- KAIROUZ HABIB10% Owner
Tickers
No tickers on record
Addresses
business
1020 E. MEADOW CIRCLE
PALO ALTO, CA, 94303
mailing
1020 E. MEADOW CIRCLE
PALO ALTO, CA, 94303
Former Names
- Anacor Pharmaceuticals Inc2013-04-08